Fresenius Medical Care US Finance III, Inc.
Fresenius Medical Care US Finance III, Inc., a prominent entity within the healthcare sector, is headquartered in the United States. Established as part of Fresenius Medical Care AG & Co. KGaA, the company focuses on providing comprehensive renal care and dialysis services, catering to patients across various regions in the US. Founded in the early 1990s, it has achieved significant milestones, including advancements in dialysis technology and patient care. The company’s core offerings include innovative dialysis products and services, which are distinguished by their commitment to improving patient outcomes and enhancing quality of life. With a strong market position, Fresenius Medical Care US Finance III, Inc. is recognised for its dedication to excellence in renal care, making it a leader in the industry.
DitchCarbon Score
How does Fresenius Medical Care US Finance III, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Medical Care US Finance III, Inc.'s score of 56 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fresenius Medical Care US Finance III, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Fresenius Medical Care AG, which may influence its climate commitments and performance metrics. While there are no documented reduction targets or climate pledges specific to Fresenius Medical Care US Finance III, Inc., it is important to note that any climate initiatives or targets would likely be inherited from its parent company, Fresenius Medical Care AG. This includes potential commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks, although specific details on these initiatives are not provided. As a subsidiary, Fresenius Medical Care US Finance III, Inc. may align its climate strategies with those of Fresenius Medical Care AG, which is expected to have established industry-standard practices for managing carbon emissions and addressing climate change. However, without specific data or targets, the company's individual climate impact remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fresenius Medical Care US Finance III, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
